Sight Sciences, Inc. filed a Form 8-K on August 10, 2026, disclosing the appointment of Kashif Rashid as Chief Legal Officer and Corporate Secretary and the concurrent departure of Jeremy Hayden from that role, both effective August 10, 2026.

Key Highlights

  • New CLO appointed: Kashif Rashid, aged 53, was appointed Chief Legal Officer and Corporate Secretary of Sight Sciences, effective August 10, 2026.
  • Base salary: Mr. Rashid will receive an initial annual base salary of $450,000, with an annual cash bonus targeted at 50% of that base salary.
  • Equity grant: Mr. Rashid is eligible for a restricted stock unit award with an aggregate value of $1,400,000, vesting in four equal annual installments beginning August 10, 2027, with a maximum cap of 280,000 shares.
  • Severance terms: If terminated without cause or upon resignation with good reason, Mr. Rashid is entitled to 12 months of base salary continuation, any unpaid prior-year bonus, and up to 12 months of COBRA premium support.
  • Prior CLO departure: Jeremy Hayden stepped down as Chief Legal Officer and Corporate Secretary on August 10, 2026, and will remain employed through August 31, 2026 to assist with transition.
  • Hayden separation terms: Subject to execution of a separation agreement and release of claims, Mr. Hayden will receive one year of base salary paid over 12 months and up to one year of COBRA benefits.

Sight Sciences CLO Transition: Rashid In, Hayden Out

According to the filing, the Board of Directors of Sight Sciences, Inc. (NASDAQ: SGHT) appointed Kashif Rashid as Chief Legal Officer and Corporate Secretary on August 6, 2026, with the appointment taking effect on August 10, 2026. Mr. Rashid's prior experience, as described in the filing, includes serving as General Counsel and later as Senior Vice President, Corporate Development, and Chief Legal Officer at Nevro Corp. from December 2017 to April 2025, when Nevro was acquired by Globus Medical. Earlier roles included Vice President, Legal at Atara Biotherapeutics, Inc., Associate General Counsel and Deputy General Counsel at St. Jude Medical, Inc., and positions at General Electric Company's Healthcare business, Loews Corporation, and the law firm Kaye Scholer, LLP.

Under his employment agreement, effective August 10, 2026, Mr. Rashid will receive a $450,000 initial annual base salary and a bonus targeted at 50% of that figure, according to the filing. The filing further discloses that Mr. Rashid will be eligible for a restricted stock unit award valued at $1,400,000 under the Company's 2021 Incentive Award Plan. The RSU award vests in four equal, consecutive annual installments commencing August 10, 2027, and the number of shares issuable will be determined by the closing price of common stock on the grant date, "provided that in no event shall the number of shares exceed 280,000," the filing states. Mr. Rashid also entered into the company's standard form of executive officer indemnification agreement.

The filing reports that Jeremy Hayden resigned as Chief Legal Officer and Corporate Secretary effective August 10, 2026, to "pursue other opportunities," and will remain employed through August 31, 2026 to assist with the transition. Subject to his execution of a separation agreement and customary release of claims, and continued compliance therewith, the company will pay Mr. Hayden one year of base salary in regular installments over the 12 months following the Separation Date and pay or reimburse up to one year of COBRA benefits, according to the filing.

What Was Disclosed

Sight Sciences disclosed the appointment of Kashif Rashid as Chief Legal Officer and Corporate Secretary, the terms of his employment agreement and equity grant, and the departure and separation terms of predecessor Jeremy Hayden, all effective August 10, 2026.